OFIXOrthofix Medical Inc.
Surgical & Medical Instruments & Apparatus
- Revenue
- $822M
- 2.9% YoY
- Operating margin
- -9.9%
- 6.4% YoY
- EBITDA
- −$4M
- 83% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- —
- $53M net debt
- AI in 10-K
- —
Red flags 1 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear—Cash flow under 80% of net income
- Dilutive SBCClear3% of revenueOver 10% of revenue
- Payouts exceed cash flowFired190% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear22% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $464M | $461M | $747M | $799M | $822M | 2.9% |
| Operating income | −$8M | −$13M | −$139M | −$85M | −$81M | 3.8% |
| Net income | −$38M | −$20M | −$151M | −$126M | −$92M | 27% |
| Operating cash flow | $18M | −$12M | −$46M | $26M | $33M | 29% |
| Capex | $18M | $21M | $60M | $35M | $35M | 0.7% |
| Stock-based comp | $15M | $18M | $36M | $32M | $29M | 12% |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $0 · 0
- Open-market sells, 12 mo
- $3M · 7
- Net
- −$3M
Pay vs performance
| Year | CEO total comp | Comp actually paid | TSR (indexed) | Peer TSR |
|---|---|---|---|---|
| FY2025 | — | — | 35 | 104 |
| FY2024 | — | — | 38 | 150 |
| FY2023 | — | — | 29 | 130 |
| FY2022 | — | — | 44 | 121 |
| FY2021 | — | — | 67 | 170 |